Smith & Nephew plc ADR
Smith & Nephew plc ADR (SNN) Implied Volatility Current
SNN implied volatility is 39%. IV Rank is 17%, placing current premiums in the bottom of their 52-week range.
Read more
Tracking SNN implied volatility helps you identify when options premiums on Smith & Nephew plc ADR are historically cheap or expensive, and where the best trades are hiding. Smith & Nephew plc ADR implied volatility reflects the market's expectation of future price movement: when SNN IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Smith & Nephew plc ADR's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For SNN, tracking metrics like SNN IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on SNN signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems.
In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where SNN implied volatility sits today versus where it has been. Our scanner ranks Smith & Nephew plc ADR implied volatility against its historical range, surfaces extremes in SNN IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Smith & Nephew plc ADR IV is rich or cheap — measure it, then act on it.
Implied Volatility
IV is compressed vs the past year - options are relatively cheap, favoring buyers.
As of September 22, 2026
Trade options with IV on your side
Track SNN IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→